More than 172,000 nursing home residents died of covid. In lawsuits, some families who lost loved ones say they were misled about safety measures or told that covid wasn’t a danger in their facilities.
Category: COVID-19
WHO Overturns Dogma on Airborne Disease Spread. The CDC Might Not Act on It.
After grave missteps in the covid pandemic, the World Health Organization revisited the science and now confirms that many respiratory viruses are inhaled as airborne particles. The new framework implies that stopping transmission relies on costly measures like ventilation and masking.
End of Internet Subsidies for Low-Income Households Threatens Telehealth Access
A federal program that helped pay for more than 23 million low-income households’ internet access runs out of money soon. The end of the subsidy launched earlier in the pandemic could have profound impacts on health care access.
Four Years After Shelter-in-Place, Covid-19 Misinformation Persists
False claims that covid vaccines cause deaths and other diseases are still prevalent despite multiple studies showing the vaccines are safe and saved lives.
Health Workers Fear It’s Profits Before Protection as CDC Revisits Airborne Transmission
Four years since the covid pandemic emerged, health care workers want rules that protect them during outbreaks. They worry the CDC is repeating past mistakes as it develops a crucial set of guidelines for hospitals, nursing homes, prisons, and other facilities that provide health care.
Covid and Medicare Payments Spark Remote Patient Monitoring Boom
Demand for help monitoring patients’ vital signs remotely has taken off since a Medicare change in 2019. Dozens of companies now push the service to help overburdened primary care doctors — and as a revenue stream. But some policy experts say its growth has outpaced oversight and evidence of effectiveness.
Covid and Medicare Payments Spark Remote Patient Monitoring Boom
Demand for help monitoring patients’ vital signs remotely has taken off since a Medicare change in 2019. Dozens of companies now push the service to help overburdened primary care doctors — and as a revenue stream. But some policy experts say its growth has outpaced oversight and evidence of effectiveness.
Why Covid Patients Who Could Most Benefit From Paxlovid Still Aren’t Getting It
Price worries, bureaucratic obstacles, and “I’m-over-covid-itis” slow uptake of a drug that’s complicated to take but often effective.
The State of the Union Is … Busy
At last, Congress is getting half of its annual spending bills across the finish line, albeit five months after the start of the fiscal year. Meanwhile, President Joe Biden delivers his annual State of the Union address, an over-the-counter birth control pill is (finally) available, and controversy erupts over new public health guidelines for covid-19 isolation. Alice Miranda Ollstein of Politico, Sarah Karlin-Smith of the Pink Sheet, and Sandhya Raman of CQ Roll Call join KFF Health News’ Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Neera Tanden, the White House domestic policy adviser, about Biden’s health agenda. Plus, for “extra credit,” the panelists suggest health policy stories they read this week that they think you should read, too.
KFF Health News’ ‘What the Health?’: Biden Wins Early Court Test for Medicare Drug Negotiations
A federal district court judge dismissed a lawsuit attempting to invalidate the Biden administration’s Medicare prescription-drug price negotiation program. But the suit turned on a technicality, and several more court challenges are in the pipeline. Meanwhile, health policy pops up in Super Bowl ads, as Congress approaches yet another funding deadline. Alice Miranda Ollstein of Politico, Lauren Weber of The Washington Post, and Rachel Cohrs of Stat join KFF Health News’ Julie Rovner to discuss these issues and more. Plus, for “extra credit,” the panelists suggest health policy stories they read this week they think you should read, too.
